2018³â Á¦29ȸ ´ëÇÑ°£ÇÐȸ Ãß°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on : 2018-09-08±³À°ÀÏÀÚ : 2018-09-08
±³À°Àå¼Ò : ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ/Hands-on: ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 5Ãþ Áø·áº´µ¿
±³À°ÁÖÁ¦ :
2018³â Á¦29ȸ ´ëÇÑ°£ÇÐȸ Ãß°è Single Topic Symposium ¹× ÃÊÀ½ÆÄ Hands-on ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ
¿¬¶ôó : 02-703-0051
À̸ÞÀÏ :
kasl@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Àü¶óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀüµî·Ï/STS: ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 10,000¿ø ºñȸ¿ø 20,000¿ø STS+Hands-on:ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 40,000¿ø ºñȸ¿ø 50,000¿ø ÇöÀåµî·Ï/STS: ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 20,000¿ø ºñȸ¿ø 30,000¿ø Hands-on ÇöÀå Á¢¼ö ºÒ°¡
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ 09:30~09:50 º¹ºÎÃÊÀ½ÆÄ °Ë»çÀÇ ½ÇÁ¦ Á¤½Â¿ø(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 5Ãþ Áø·áº´µ¿ 09:50~12:30 ÃÊÀ½ÆÄ Hands-on ¹é¼ø±¸, Á¤½Â¿ø, ¼ºÇʼö, ±èÅÂÇü, À¯¾çÀç, ¼Õ¿ø, Á¶È¿Á¤, ÀüÃæȯ, ÀÓ¼º±Õ, Á¤±Ý¸ð, ¾çÈñÂù(¿¬¼¼´ë ¿øÁÖÀÇ´ë, ¼øõÇâÀÇ´ë, °¡Å縯ÀÇ´ë, °í·ÁÀÇ´ë, ºÐ´çÁ¦»ýº´¿ø, ¿ø±¤ÀÇ´ë, ¾ÆÁÖÀÇ´ë, Àü³²ÀÇ´ë, ÀüºÏÀÇ´ë, ¿¹¼öº´¿ø)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ 13:40~14:00 Epidemiology and Disease Burden ÀÌâÈÆ(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ 14:00~14:20 Update on Pathogenesis Àü´ë¿ø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ 14:20~14:40 Secondary Causes of Fatty Liver ½ÉÀçÁØ(°æÈñÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 14:40~15:00 Screening, Diagnosis, and Assessment Á¶¿ë±Ù(¿¹¼öº´¿ø)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 15:00~15:20 Screening for Extrahepatic Complications Á¶ÁÖ¿¬(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 15:20~15:40 Current and Future Management Á¶¿ë±Õ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 16:00~16:20 Clinical Management and Decision of NAFLD with metabolic syndrome Á¶Àº¿µ(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 16:20~16:40 Clinical Management and Decision of NAFLD without overt metabolic syndrome ±èÈÖ¿µ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 09¿ù 08ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±Ý 16:40~17:00 Clinical Management and Decision of NASH with fibrosis ¹ÚÁØ¿ë(¿¬¼¼ÀÇ´ë)